BIOLOGICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING DENDRITIC CELLS, NATURAL KILLER CELLS AND CYTOTOXIC T CELLS

The present invention relates to a pharmaceutical composition for preventing or treating cancer and, more specifically, the present invention comprises dendritic cells, natural killer cells and cytotoxic T cells, and thus exhibits anticancer effects that are better than those of when each type of ce...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LEE, Na Hye, LEE, Ha Na, HAM, Won Kook, PARK, Jin Ju, CHE, Denis Nchang, LEE, Hyun Ji, LEE, Jong Kyun, KIM, Yea Won, LEE, Hyo Jung
Format:	Patent
Sprache:	eng ; fre ; kor
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a pharmaceutical composition for preventing or treating cancer and, more specifically, the present invention comprises dendritic cells, natural killer cells and cytotoxic T cells, and thus exhibits anticancer effects that are better than those of when each type of cell is used alone. In addition, if a pharmaceutical composition of the present invention comprises co-cultured dendritic cells, natural killer cells and cytotoxic T cells, anticancer effects that are better than those of when each type of cell is used alone or used in a simple combination are exhibited. La présente invention concerne une composition pharmaceutique destinée à prévenir ou à traiter le cancer et, plus spécifiquement, la présente invention comprend des cellules dendritiques, des cellules tueuses naturelles et des lymphocytes T cytotoxiques, et présente ainsi des effets anticancéreux qui sont meilleurs que ceux obtenus lorsque chaque type de cellule est utilisé seul. De plus, si une composition pharmaceutique de la présente invention comprend des cellules dendritiques, des cellules tueuses naturelles et des lymphocytes T cytotoxiques co-cultivés, des effets anticancéreux qui sont meilleurs que ceux présentés lorsque chaque type de cellule est utilisé seul ou utilisé dans une combinaison simple sont présentés. 본 발명은 암의 예방 또는 치료용 약학 조성물에 관한 것으로, 보다 상세하게는 수지상 세포, 자연 살해 세포 및 세포 독성 T 세포를 포함함으로써 각 세포를 단독으로 이용하는 경우에 비해 우수한 항암 효과를 나타낸다. 또한, 본 발명의 약학 조성물이 서로 공동 배양된 수지상 세포, 자연 살해 세포 및 세포 독성 T 세포를 포함하는 경우, 각 세포를 단독 혹은 단순 혼합으로 이용하는 경우에 비해 우수한 항암 효과를 나타낸다.